• Meriscreen Malaria pLDH Ag

Meriscreen Malaria pLDH Ag

MeriScreenTM Malaria pLDH is a single test device for the qualitative detection of P. falciparum specific pLDH (Plasmodium falciparum specific lactate dehydrogenase) and pLDH (Plasmodium lactate dehydrogenase) specific to other Plasmodium species (P. vivax, P. ovale and P. malariae) in human whole blood samples

  • Use of anti - pLDH specific for PAN malaria

  • Use of anti - pLDH specific for Plasmodium falciparum

  • Use of monoclonal antibodies for better specificity

  • Immunochromatography test for diagnosis of malaria parasite – Plasmodium falciparum

Benefits

  • 01

    No preprocessing of samples required (5 microlitre). 

  • 02

    Can be easily deployed as point of care testing in remote areas.

  • 03

    Clear background for easy visualization and interpretation.

  • 04

    Results in 20 minutes.

  • 05

    Diagnostic Sensitivity > 95%.

  • 06

    Diagnostic Specificity > 95%.

Indication

  • Detection of Plasmodium infections

  • To differentiate infection by Plasmodium falciparum from the non P. falciparum species

Intended Use One step immunochromatographic assay for qualitative detection of infection with Plasmodium species causing malaria
Principle Sandwich Immunoassay
Technique Lateral flow(ICT)
Detection Plasmodium lactate dehydrogenase specific to Plasmodium falciparum species (Pf - pLDH)
Plasmodium lactate dehydrogenase common to all human Plasmodium species (PAN - pLDH)
Capture Pf Region - Plasmodium lactate dehydrogenase specific to Plasmodium falciparum (pf pLDH)
PAN Region - Plasmodium lactate dehydrogenase common to all human Plasmodium species (PAN - pLDH)
Conjugate Antibodies specific to pLDH coupled with colloidal gold
Type of Specimen required Whole Blood
Specimen Volume 5 ml
Result interpretation time 20 minutes
Diagnostic Sensitivity > 95%
Diagnostic Specificity > 95%

Ordering Information

Product Code Material Description Pack Size
MVLRPD-01 MeriScreen Malaria pLDH Ag 30 Tests
Meriscreen Malaria pLDH Ag